Neovacs S.A. (EPA:ALNEV)

Neovacs Revenue

Neovacs had revenue of 392.39K EUR in the half year ending June 30, 2024, with 684.79% growth. This brings the company's revenue in the last twelve months to 823.43K, up 1,439.62% year-over-year. In the year 2023, Neovacs had annual revenue of 533.41K with 47,868.71% growth.

• Revenue (ttm): 823.43K
• Revenue Growth: +1,439.62%
• P/S Ratio: 0.00
• Revenue / Employee: 37.43K
• Employees: 22
• Market Cap: 3.61K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	533.41K	532.30K	47,868.71%
Dec 31, 2022	1.11K	-21.43K	-95.07%
Dec 31, 2021	22.54K	-7.24K	-24.32%
Dec 31, 2020	29.78K	-65.37K	-68.70%
Dec 31, 2019	95.15K	88.15K	1,259.34%